Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
The Science of the Total Environment|May 8, 2024
Comprehensive analysis of metal(loid)s and associated metal(loid) resistance genes in atmospheric particulate matterXiu-Peng Liang, He-Jing Wang, Jie-Ru Zheng, et al.
International Journal of Oncology|June 26, 2008
Functional domains of CCN1 (Cyr61) regulate breast cancer progressionJames O'Kelly, Alice Chung, Nathan Lemp, et al.
Breast Cancer Research and Treatment|February 5, 2010
Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancerGottfried E Konecny, Giovanni Pauletti, Michael Untch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapySteven J O'Day, Peter D Boasberg, Lawrence Piro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patientsKazuo Koyanagi, Steven J O'Day, Rene Gonzalez, et al.
Cancer Chemotherapy and Pharmacology|May 14, 2015
Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkersZev A Wainberg, Heloisa P Soares, Ravi Patel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2007
Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expressionTakahiro Kimura, Richard C Koya, Laura Anselmi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trialKazuo Koyanagi, Steven J O'Day, Rene Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanomaSteven J O'Day, Michael B Atkins, Peter Boasberg, et al.
Journal of Geriatric Oncology|July 9, 2014
Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysisPeter Ward, J Randolph Hecht, He-Jing Wang, et al.
Pageof 8